D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 102 Citations 53,252 394 World Ranking 3420 National Ranking 1952

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Alzheimer's disease

His primary areas of investigation include Psychiatry, Alzheimer's disease, Internal medicine, Dementia and Placebo. Alzheimer's disease is the subject of his research, which falls under Disease. His Disease research is multidisciplinary, relying on both Natural history and Neuroscience.

His research on Internal medicine frequently connects to adjacent areas such as Surgery. His Dementia study combines topics in areas such as Pharmacotherapy, Confidence interval, Geriatrics and Quality of life. His Placebo research incorporates themes from Anesthesia, Galantamine, Central nervous system disease and Endocrinology.

His most cited work include:

  • Dementia prevention, intervention, and care (2073 citations)
  • A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease (2070 citations)
  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)

What are the main themes of his work throughout his whole career to date?

Lon S. Schneider mostly deals with Disease, Psychiatry, Internal medicine, Clinical trial and Alzheimer's disease. His Disease study integrates concerns from other disciplines, such as Gerontology, Cognition, Neuroscience, Intensive care medicine and Biomarker. His Psychiatry study combines topics from a wide range of disciplines, such as Dementia and Clinical psychology.

Lon S. Schneider works mostly in the field of Internal medicine, limiting it down to topics relating to Placebo and, in certain cases, Randomized controlled trial, Adverse effect, Tolerability and Anesthesia, as a part of the same area of interest. His Clinical trial research is multidisciplinary, incorporating elements of Memantine, Physical medicine and rehabilitation, Cholinesterase, Drug development and Physical therapy. His Alzheimer's disease study incorporates themes from MEDLINE, Pharmacology, Cognitive disorder and Cognitive decline.

He most often published in these fields:

  • Disease (31.91%)
  • Psychiatry (30.93%)
  • Internal medicine (29.57%)

What were the highlights of his more recent work (between 2014-2021)?

  • Disease (31.91%)
  • Clinical trial (27.43%)
  • Internal medicine (29.57%)

In recent papers he was focusing on the following fields of study:

Disease, Clinical trial, Internal medicine, Alzheimer's disease and Dementia are his primary areas of study. His Disease research incorporates elements of Biomarker and Neuroimaging, Cognition, Neuroscience. His research integrates issues of Psychological intervention, Observational study, Physical medicine and rehabilitation and Adverse effect, Pharmacology in his study of Clinical trial.

In his research on the topic of Internal medicine, Tolerability is strongly related with Placebo. He has included themes like Psychiatry, Psychomotor agitation, Gerontology, Citalopram and Cognitive decline in his Alzheimer's disease study. Lon S. Schneider has researched Dementia in several fields, including MEDLINE, Intervention, Family medicine, Intensive care medicine and Cohort.

Between 2014 and 2021, his most popular works were:

  • Dementia prevention, intervention, and care (2073 citations)
  • Defeating Alzheimer's disease and other dementias: a priority for European science and society (768 citations)
  • Analysis of shared heritability in common disorders of the brain (726 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

The scientist’s investigation covers issues in Disease, Alzheimer's disease, Dementia, Clinical trial and Internal medicine. His Disease research incorporates themes from Psychiatry, Cognition, Neuroscience, Intensive care medicine and Biomarker. His Psychiatry research is multidisciplinary, incorporating perspectives in Number needed to treat and Quality of life.

His research integrates issues of Placebo and Gerontology in his study of Alzheimer's disease. Lon S. Schneider has researched Clinical trial in several fields, including Adverse effect, Pharmacology, Urinary system and Randomized controlled trial. His work in Internal medicine tackles topics such as Oncology which are related to areas like Positron emission tomography.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Mary Sano;Christopher Ernesto;Ronald G. Thomas;Melville R. Klauber.
The New England Journal of Medicine (1997)

3198 Citations

Dementia prevention, intervention, and care

Gill Livingston;Gill Livingston;Andrew Sommerlad;Vasiliki Orgeta;Sergi G Costafreda;Sergi G Costafreda.
The Lancet (2017)

2987 Citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2389 Citations

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Lon S. Schneider;Karen S. Dagerman;Philip Insel.
JAMA (2005)

1812 Citations

Common variants at MS4A4/MS4A6E , CD2AP , CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)

1580 Citations

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Lon S. Schneider;Pierre N. Tariot;Karen S. Dagerman;Sonia M. Davis.
The New England Journal of Medicine (2006)

1272 Citations

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.

Gary W. Small;Peter V. Rabins;Patricia P. Barry;Neil S. Buckholtz.
JAMA (1997)

1255 Citations

Diagnosis and Treatment of Depression in Late Life: Consensus Statement Update

Barry D. Lebowitz;Jane L. Pearson;Lon S. Schneider;Charles F. Reynolds.
JAMA (1997)

1244 Citations

A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

Margaret J. Knapp;David S. Knopman;Paul R. Solomon;William W. Pendlebury.
JAMA (1994)

1206 Citations

Defeating Alzheimer's disease and other dementias: a priority for European science and society

Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard.
Lancet Neurology (2016)

1131 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lon S. Schneider

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 321

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 303

Jeffrey L. Cummings

Jeffrey L. Cummings

University of Nevada, Las Vegas

Publications: 196

Clive Ballard

Clive Ballard

University of Exeter

Publications: 179

Dag Aarsland

Dag Aarsland

King's College London

Publications: 156

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 142

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 142

Bruno Vellas

Bruno Vellas

Federal University of Toulouse Midi-Pyrénées

Publications: 140

Nathan Herrmann

Nathan Herrmann

Sunnybrook Health Science Centre

Publications: 138

Bengt Winblad

Bengt Winblad

Karolinska Institute

Publications: 136

Serge Gauthier

Serge Gauthier

McGill University

Publications: 132

David A. Bennett

David A. Bennett

Rush University Medical Center

Publications: 132

Jin-Tai Yu

Jin-Tai Yu

Fudan University

Publications: 126

Lan Tan

Lan Tan

Qingdao University

Publications: 116

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 114

Pieter Jelle Visser

Pieter Jelle Visser

Maastricht University

Publications: 109

Trending Scientists

Fauzia Ahmad

Fauzia Ahmad

Temple University

Mohammad Haghighi

Mohammad Haghighi

Sahand University of Technology

Ling-Shu Wan

Ling-Shu Wan

Zhejiang University

Frederick A. Rueggeberg

Frederick A. Rueggeberg

Augusta University

Jos C. S. Kleinjans

Jos C. S. Kleinjans

Maastricht University

John J. Wasmuth

John J. Wasmuth

University of California, Irvine

Frederick T. Short

Frederick T. Short

University of New Hampshire

Aaron M. Bauer

Aaron M. Bauer

Villanova University

Karin Ljung

Karin Ljung

Swedish University of Agricultural Sciences

Blaise Genton

Blaise Genton

University of Lausanne

Manmohan Singh

Manmohan Singh

Beam Therapeutics

Elizabeth R. Zell

Elizabeth R. Zell

Centers for Disease Control and Prevention

Mervyn Greaves

Mervyn Greaves

University of Cambridge

Katsuhiko Suzuki

Katsuhiko Suzuki

Japan Agency for Marine-Earth Science and Technology

Raquel Nieto

Raquel Nieto

Universidade de Vigo

W. Kyle Simmons

W. Kyle Simmons

Oklahoma State University Center for Health Sciences

Something went wrong. Please try again later.